Emcure Pharmaceuticals informs about outcome of board meeting

21 Jun 2025 Evaluate
Emcure Pharmaceuticals has informed that pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), read with Schedule III of aforesaid regulation, the Board of Directors of the Company at its meeting held today, Saturday, June 21, 2025, has transacted and approved the following businesses: Approval for acquisition of Equity Shares of Zuventus Healthcare, Subsidiary of the Company; Approval of the requests received from certain members of Promoter and Promoter Group for seeking re-classification from ‘Promoter and Promoter Group’ category to ‘Public’ category of the Company; Incorporation of a wholly-owned Subsidiary by the name ‘Emcure Wellness Private Limited’ in Pune, Maharashtra, India.

The above information is a part of company’s filings submitted to BSE.

Emcure Pharma Share Price

1395.15 -9.10 (-0.65%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×